The mass media are a primary source of health information for most Americans (Burns et al. 1995; Conrad 1999; Nelkin and Lindee 1995) , including healthcare providers (Geller et al. 2003; Phillips et al. 1991) . Nevertheless, coverage of medical stories is often superficial, inaccurate, sensationalized, or inadequate (Kinsella 1989; Klaidman 1991; Moynihan et al. 2000; Schuchman and Wilkes 1997) The mass media have avidly reported progress in genetic research (Tambor et al. 2002) , including the discovery of genes related to human diseases and behavioral traits. According to some observers, there is an increasing tendency for the press to ascribe a genetic etiology to disease and behavioral traits (Nelkin and Lindee 1995) , to give greater publicity to reports attributing complex traits to genes than to contradictory reports (Conrad 1997; Conrad 2001; Conrad and Weinberg 1996) , and to exaggerate the wide and imminent applicability of genetic discoveries (Geller, Bernhardt, and Holtzman 2002; Petersen 2001) . Condit et al., on the other hand, found little temporal increase in "the degree of genetic determinism" conveyed in American newspapers and magazines (Condit, Ofulue, and Sheedy 1998) .
Media stories about health, science in general, or genetics in particular have seldom been subject to content analysis or an assessment of their accuracy and balance (Atkin and Arkin 1990) . Oxman et al. (1993) constructed an Index of Scientific Quality for health reports in the lay press. This tool uses subjective assessments about the applicability, validity, and practical importance of the information that is reported. In genetics-related research, Condit et al. developed a coding scheme to assess temporal trends in discussions of genetic determinism but not in other aspects of genetics stories in the mass media (Condit, Ofulue, and Sheedy 1998) .
We undertook to develop an instrument to assess the content and balance of mass media stories about genetic discoveries relevant to human diseases. In this paper, we describe the construction of an instrument most of whose items meet two criteria: (1) consumers with an interest in science news would like them included and (2) scientists and journalists deem them important. A few additional items assess a story's overall quality and whether it is balanced. We also report the reliability of the instrument, as measured by independent scoring by at least two raters, and its ability to detect variability among stories emanating from each of two genetic discoveries. Our long-term goal is to explain the factors influencing variability in the content, accuracy, and balance of media reports of genetic discoveries.
Methods

Instrument Development
Initially, we extracted items for inclusion in the instrument from original scientific reports, university press releases, and media stories of 5 genetic discoveries made by researchers at the Johns Hopkins University School of Medicine.
Consumer input. Through advertisements in the Baltimore Sun and Baltimore Teacher's Union Newsletter, we invited individuals to phone us if they were interested in participating in a two-hour discussion group to talk about science and the media. The consumers were offered $30 and a light supper. Those who responded were asked their age, gender, highest grade in school, race-ethnicity, the media sources they used, and their availability on several tentative evening dates. Two groups were constructed, one consisting of college graduates or higher, the other of people without a college degree. The two dates available to the greatest number of respondents in each category were selected. Both groups met in the spring of 1999. Groups were cofacilitated by two of the authors. A court stenographer transcribed the conversations, enabling us to identify the opinions of individual participants. Information on occupation was obtained at the start of the focus group as people introduced themselves by first name. After transcribing, names were replaced by codes and the names discarded.
During the focus groups, participants were asked: "If a discovery of a gene associated with a disease were being reported, what would you want to have included in the report?" The items important to consumers that were not included in our original list were added to the instrument. We did not share the items that we extracted from the original reports with the focus groups.
Review of instrument by scientists and journalists. In 2000, we sent a list of thirty-one items that had been formulated at the time to fifteen scientists at the Johns Hopkins Medical Institutions, whose genetic research brought them into contact with journalists, and to twenty-one journalists nationwide who had written news stories pertaining to genetics and health. The recipients were told that the items would be used to evaluate newspaper stories published within three days of the report of a discovery of an association between a gene and a disease in a peer-reviewed scientific journal. They were asked to rate each item as essential, discretionary, or beyond the scope of such a story.
The involvement of consumers, scientists, and journalists in development of the instrument was approved by the Johns Hopkins School of Medicine Joint Committee on Clinical Investigation (Application #98-03-12-07).
Scoring
Content and accuracy. We included content items whose presence or absence could be assessed and whose accuracy could be established when they were present. Not all of the items in our instrument are relevant to every genetic discovery. Therefore, we "customized" the instrument for each genetic discovery by omitting items not relevant to that particular discovery. The customizers, who had training in genetics and epidemiology but had no special knowledge about the individual discoveries, based their judgments on the relevance of items to the content of the original scientific report, a press release (when one was available), and a sampling of media stories emanating from the scientific report of the particular discovery. The customizers occasionally had to look up information in the scientific literature to provide criteria used by the raters in assessing accuracy, for example, the prevalence of a disease.
Scoring was performed on media stories emanating from two widely covered genetic discoveries: the 1994 identification of the BRCA1 gene (Miki et al. 1994 ) and the 1996 report linking prostate cancer to markers on chromosome 1 (Smith et al. 1996) We used the Lexis-Nexis database (LexisNexis Research Software, Miamisburg OH) to identify media stories, using the keywords breast cancer and gene, and prostate cancer and gene, for the two discoveries, respectively. Word counts of each story were obtained from the Lexis-Nexis database. For breast cancer, 17 major newspaper stories, 6 wire service stories, and 4 television transcripts related to the discovery appearing between 13 September and 15 September 1994 were identified. Four magazine stories appearing between 13 September and 26 September 1994 were also analyzed. For the prostate cancer linkage discovery, 12 major newspaper stories, 2 wire service stories, and 2 radio/television transcripts appearing between 21 November and 25 November 1996 were identified. No radio stories describing the BRCA1 discovery and no magazine stories describing the prostate cancer linkage were identified.
For each item on the scoring instrument, a rater gave a score of 1 if the story presented the information accurately, a score of -1 if it presented it inaccurately (error of commission), or a score of 0 if the story did not present the information at all (error of omission). For items in which inaccuracy would not be immediately apparent to the raters, the customizers defined what was accurate. The total content score for each story was the sum of the individual item scores divided by the total number of relevant items × 100.
Usually, information considered most important by reporters appears at the beginning (leads) of their stories. In order to see whether certain items appeared more often in the leads than in the rest of the story, raters flagged items in the leads. Table 1 presents the formula used to delineate the lead from the main body of stories. Scoring was identical for items regardless of where they appeared in the story.
Balance. By balance, we mean whether the story presented limitations or risks of the discovery, included critical comments of other scientists, and did not exaggerate the relevance of the discovery to human health. Very few of the content items reflect balance. Therefore, the raters scoring the stories answered three questions regarding exaggeration, risks of the discovery, and opinions of experts (Table 2) . A higher score on each item denoted greater balance. For each story, the sum of the scores on each of these three items was the total balance score.
Overall assessment. The raters also evaluated the overall quality of each story, from 1 for poor to 5 for excellent (Table 2) . We did not evaluate stories' headlines.
Reliability
To assess the reliability of the instrument, three raters independently assessed the presence and accuracy of items in seven randomly chosen prostate stories. Two raters independently scored sixteen randomly chosen breast 462 SCIENCE COMMUNICATION cancer stories. In the initial stage of scoring, the raters compared the scores and discussed disagreements and uncertainties about how to score an item. When they could not resolve the problem, they met with at least one customizer who helped resolve it. Using the new criteria, the initially-scored stories were rescored and additional stories were scored as well. (1 = no; 2 = yes) 38.7 18.8 3 Does the report present a balanced selection of expert opinions? (0 = no quotations were included; 1 = quotes were only from those directly connected with the research and were only positive; 2 = quotes from outside experts were included but were only positive; 3 = quotes from individuals included some that were supportive and others that were critical) 83.3 50.0
Mean total balance score ± SD (total possible score = 7) 4.9 ± 1.5 5.2 ± 1.8 Overall assessment (1 = poor; 5 = excellent) Mean overall assessment score ± SD 3.0 ± 1.0 3.3 ± 1.0 NOTE: NA = not applicable. 
Data Analysis
Cohen's kappa was used to calculate interrater reliability of each of the three components of the instrument (content items, balance, overall quality). We also calculated the percentage of interrater agreement for each content item by dividing the number of stories for which two independent raters had assigned an identical score by the total number of stories dually scored for that item.
Chi-square tests were used to compare the proportion of responding scientists to the proportion of responding journalists who designated each instrument item essential, and to compare the proportion of BRCA1 stories that included each item to that of prostate cancer stories. Kendall's tau-b was computed to compare the total balance scores and overall assessments to the content scores. For this analysis, the content scores were divided into quintiles. Pearson correlation coefficients were computed to compare the percentage of scientists and journalists who rated each item as essential, the percentage of journalists deeming an item essential with the percentage of stories containing the item, and the total content scores of stories with the length of stories.
Results
Instrument Development
The final instrument (Table 2) contains thirty-eight objectively measurable content items divided into six sections: description of research (items 1-6), credibility of research (items 7-12), genetics and epidemiology of the gene-disease association (items 13-21), description of the disease in all affected people (items 22-28), description of the disease in only those people in whom the disease can be attributed to the gene (or to a linked marker) that has been discovered (items 29-33), and implications of the discovery (items 34-38). The instrument also contains three balance questions and an overall assessment.
Consumer input. A total of twenty-three consumers participated in the focus groups: twelve were female and eleven were male. The participants ranged in age from twenty-three to sixty-four years (mean ± SD = 44.6 ± 13.8 years); 78 percent were Caucasian and the remainder were African American. Forty-eight percent had a college degree or higher, and only fourteen percent had no formal education beyond high school. Nine worked in the commercial sector, five were primary or secondary school teachers, five worked in ancillary health fields, and the remaining four were in miscellaneous fields.
When asked what should be included in a media report about a new genetic discovery, the consumers mentioned the same items that we identified prior to the focus groups, but they wanted more detailed information. Additional items derived from consumer input, and included in the instrument, were: why the research was undertaken (item 1), in what species and over what time frame (items 2, 5), more information on the credibility of the research (items 7-10), how serious the disease is, how common it is (items 22-26), and how frequently the genetic mutation(s) associated with the disease occur in the population (item 15). They were curious about how mutation could lead to the disease and what other illnesses a mutation could cause (items 19, 16) .
In addition to the items suggested by consumers, we added items to clarify ambiguities that arose during the reliability assessment. Items 29 through 33 enable us to assess how clearly a story distinguished between the manifestations and/or management of the general and gene-specific forms of the disease. Items 28 and 33 permit us to distinguish prevention from cure and/or amelioration (items 27 and 32) for both forms of the disease. Item 21 was added to indicate whether a story mentions the role of other genetic factors as distinct from environmental factors in disease etiology.
Review of instrument by scientists and journalists.
Of the scientists whom we contacted, 73.3 percent (eleven out of fifteen) returned an evaluation of our instrument. The response rate was 76.1 percent (sixteen out of twentyone) for the journalists. We have insufficient demographic, educational, or professional information to compare respondents to nonrespondents. Table 3 indicates the percentage of scientists and journalists who deemed each item essential. The correlation between the percentages of scientists and journalists rating each item as essential was .80 (p < .01). Six items (2, 6, 10, 12, 13, 37) were deemed essential by 75 percent or more of both scientists and journalists. Four items (3, 8, 14, 26) were considered essential by more than 50 percent of journalists but fewer than 50 percent of scientists; there were no items considered essential by more than 50 percent of scientists but not 50 percent of journalists. The only item for which the difference between the proportion of scientists and journalists choosing "essential" approached significance was the "duration of the study" (item 5). No scientist thought this needed to be mentioned, whereas 40 percent of the journalists thought it was essential (X 2 Fisher's exact , p = .013). Eleven of the thirty-three items evaluated by scientists and journalists were rated "beyond the scope of a news story about a gene that has led to a genetic test for a disease" by at least one respondent. However, all thirty-three items were rated essential by at least three of the twenty-seven respondents. Consequently, we considered all items to have sufficient content validity to be retained in the instrument. Moreover, items rated essential by only a few scientists or journalists were all generated by consumers, adding another reason to leave them in the instrument.
Reliability of Instrument
Interobserver reliability was satisfactory for the thirty-two content items included in the instrument for either BRCA1 or prostate cancer (kappa = .74). (Customizers excluded six items [14, 25, and 30-33] for both discoveries as well as items 15 and 26 for BRCA1 and items 1, 5, 16, and 19 for prostate cancer [see Table 2 ].) Twenty-two items yielded more than 90 percent and seven at least 80 percent agreement between two raters. Of the remaining four items, the least reliable was item 38 (56.5 percent agreement). This reflects the difficulty of assessing whether terms have been adequately defined in articles for a lay audience. Items 2, 22, and 37 also had relatively low agreement (73.9 percent, 70.0 percent, and 73.9 percent respectively). For item 2, the discrepancy between raters was due to a rater's occasionally giving a score of 1 when relevance to humans was mentioned. For item 22, disagreement resulted from differing interpretations of whether prevalence was described and, for item 37, from differing interpretations of whether a group or subpopulation was mentioned. Balance questions 1 and 2 were less reliable, with a combined kappa of .44 and agreement between observers 73 percent of the time. Balance question 3 had a kappa of 1.0, with 100 percent agreement between observers.
Using the 5-point scale for overall quality rating (Table 2) , reliability was low, with a kappa of .27 and interobserver agreement of only 48 percent. When trichotomized as 1 versus 2/3/4 versus 5, the kappa barely increased to .28, but the interobserver agreement increased to 88 percent.
Two of the four raters had expertise in genetics. Their ratings were not different from those of the other two raters.
Variability in Content and Accuracy of Stories
The number of content items applicable to BRCA1 stories was thirty and to prostate cancer stories, twenty-eight. Final scores of all stories were based on revised scoring criteria incorporating changes to improve reliability. For BRCA1 stories, total content scores ranged from 16.7 percent to 70.0 percent, with a mean ± SD of 46.8 ± 13.8. For prostate cancer stories, the range was 11.5 percent to 84.6 percent, with a mean ± SD of 55.5 ± 18.6. Low scores were, for the most part, attributable to errors of omission rather than errors of commission. Raters assigned a -1, for inaccurate information, only five times across all stories and items. Three BRCA1 stories stated that smoking was an environmental risk factor for breast cancer. At the time, no published data supported this contention, although a recent study reports an association between long-term and high-intensity smoking and breast cancer (Terry, Miller, and Rohan 2002) . One BRCA1 story indicated that the test for BRCA1 would be used to screen women in general and not just those with a family history (item 37). At the time, BRCA1 testing was still in a research phase and was limited to women with at least one affected first-degree relative. (The latter is still generally the case.) One prostate cancer story falsely stated that prostatectomy was not an option because of potential complications of impotence and incontinence. Although such complications do occur, they do not invalidate prostatectomy as an option.
Story length was correlated with the total content score (r = .537, p < .001). Very short stories covered fewer items than did longer stories. Stories exceeding 1,000 words, however, did not cover a greater percentage of applicable items. The longer stories emphasized a human-interest angle and provided more background or greater depth. These factors were not scored in our instrument.
For both breast and prostate cancer stories, three items were included in 80 percent or more of stories (Table 2 ). Item 35, describing potential clinical applications, was the item covered most often. Items 9, where the research was done, and 17, proportion of people with the disease who have the genotype/marker, were also mentioned in more than 80 percent of stories of both discoveries. Prevention or early detection (Item 28) of prostate cancer was mentioned significantly less frequently (six out of sixteen stories) than was that of breast cancer (twenty-five out of thirty-one stories) (X 2 , p = .009). Item 35, as well as whether the discovery furthered understanding of the disease (item 34 only for breast cancer) and whether a genetic mutation in the gene in question is usually inherited or acquired (item 13) appeared more frequently in the lead paragraphs than later in the stories. Items 10, 12, and 22 (see Table 2 ) appeared in more than half of the stories about both discoveries but were mentioned in the lead paragraphs less than half of the time. Fewer than half of the stories indicated the group to which the discovery pertains: families with multiple cases of the cancer, usually with early age of onset (item 37).
Inclusion of items deemed essential.
The correlation between the percentage of journalists deeming an item essential and the percentage of stories containing the item was of borderline significance (r = .39, p = .05). Of the seventeen items deemed essential by more than 50 percent of journalists (and 56 percent of scientists), eight (47 percent) appeared in fewer than 50 percent of the stories. Although 100 percent of journalists (and scientists) thought it essential that stories include the species of subjects (item 2), only 45 percent of stories included this item. None of the forty-seven stories mentioned whether the investigators would benefit from the discovery (item 8), although 42 percent of scientists and 53 percent of journalists deemed it an essential item. Funding source (item 7) was deemed essential by 29 percent of journalists and 36 percent of scientists but appeared in only one story (2 percent).
Variability in balance and overall quality of stories. Raters indicated that 36 percent of BRCA1 stories and 25 percent of prostate cancer stories exaggerated the benefits of the discovery (balance question 1, Table 2 ); 39 percent of BRCA1 stories and 19 percent of prostate stories failed to mention risks of the discovery (balance question 2, Table 2 ). For more than 80 percent of BRCA1 stories and half of prostate cancer stories, the raters felt the story did not present a balanced selection of expert opinion (balance question 3, Table 2 ). Only 8 percent of BRCA1 and 29 percent of prostate stories included quotes that were supportive and others that were critical (not shown in Table 2 ).
The mean overall assessment scores are shown in Table 2 . No story received a 1. Stories that included more applicable items were generally perceived by the raters to be of higher quality. However, two of the four stories that received a rating of 5 were not among the stories with the highest percentage of applicable items, receiving scores of 54 percent and 65 percent. Raters' notes in the balance sections of the instrument indicated that these stories rated highly because they contained enough information, were clearly written, and did not exaggerate the significance of the discovery.
Correlations between subscores. Content score correlated with the overall assessments (r = .45; Kendall's tau-b, p < .001) and with the total balance score (r = .50, p < .001). Total balance and overall scores were also correlated (r = .52; Kendall's tau-b, p = .001).
Discussion
The only previous effort to assess the scientific quality of media stories (Oxman et al. 1993 ) used measurements that required subjective judgments of the raters. More objective criteria, including some that are included in the content part of our instrument, have been used to evaluate media reports of the benefits and risks of medications (Moynihan et al. 2000) , and media coverage of scientific meetings (Schwartz, Woloshin, and Baczec 2002) , but not scientific content. To our knowledge, the present study represents the first attempt to draw on the input of consumers, scientists, and journalists to establish objectively measurable criteria by which to assess media stories emanating from discoveries reported in peer-reviewed scientific journals. We were surprised by the extent of agreement between all three groups about what should be covered. Our study was limited to genetic discoveries related to human diseases.
Consumers' attendance at the focus groups and the views they articulated indicated that all participants were interested in science reporting by the mass media. For many participants, their interest was motivated primarily by how a discovery might affect them, particularly their health. For a minority, a broader interest in science, regardless of a discovery's potential effect on them personally, provided the motivation.
The consumers who participated were not expert in science or genetics. Some of them could not understand how diseases that did not occur until adulthood could be due to inherited mutations. Their insistence on having stories include evidence of the credibility of the research often stemmed from their admitted inability to judge the quality of the science and, consequently, their reliance on trusted authorities. Similarly, the more details a story provided, the more likely they were to accept the credibility of the research. They were particularly dismayed when media stories extrapolated from animal studies to human problems. Hence, they thought media stories should indicate the species in which the discovery was made. That the consumers wanted more detail is consistent with the advice given recently by science writers who have urged scientists to "wade into the methods" when talking to journalists to ensure that the journalist is able to evaluate the credibility of the research (Highfield 2000; Rensberger 2000) .
Most of the items important to consumers were "essential" to scientists and/or journalists.
For all but one of the items they evaluated, there was no significant difference between the proportion of scientists and that of journalists who rated the item as essential. Several items were mentioned in these stories less often than journalists thought they should be. The journalists whose views we solicited were selected because they were established science and health writers. It is possible that their views on what should be covered were not representative of the writers of the stories we analyzed; only five of our respondents wrote eight of the forty-seven stories analyzed. A second possibility is that journalists do not have ultimate control over what is published. Their editors may truncate or otherwise modify an article before it is released. A third possibility is that journalists' attitudes may have changed during the period between 1994 and 1996, when the stories were written, and 2000, when we surveyed journalists, and by which time many more gene discoveries had been published. This difference in time may be relevant to two items: benefits that investigator(s) may derive from the discovery, which approximately onehalf of scientists and journalists deemed essential, and funding sources, which 30 percent of scientists and 25 percent of journalists thought was essential. No story included the first item. None of the prostate cancer stories and only 3.2 percent of the BRCA1 stories included the second. That the year in which the story was written made a difference is unlikely in view of the finding that press releases by leading medical journals of papers published in 2000 mentioned funding source in only five of twenty-two studies supported by industry and "failed to highlight conflicts of interest" . Moynihan et al. (2000) sampled newspaper and television stories published between 1994 and 1998 that reported the benefits and risks of four frequently used medications. Eighty-five of these stories cited a scientific report in which the ties of the investigators to manufacturers were disclosed, but only thirty-three of them mentioned the ties. The authors did not analyze their data by year of publication. We are in the process of analyzing trends in the inclusion of specific items in stories reporting genetic discoveries between 1996 and 2000.
Because scoring of the first (content) part of the instrument was based on the presence or absence of each item, we obtained high interrater agreement. The reliability of measurement of all included content items was good (kappa = .74). Only four of the items had interrater agreement of less than 80 percent. We have established more stringent criteria for two of these items. For item 2, a 1 is scored only when the species of the research subjects is mentioned. For item 22, a 1 is scored only when prevalence is presented directly as a rate or when the number of people affected is given for a population of well-known size. We have deleted item 38, terminology, from the instrument. We have no explanation for the relatively low agreement for item 37. Among the content items, errors of omission were observed much more often than errors of commission.
The interobserver reliability on the first two of the three items in the second part of the instrument (balance) was much lower (kappa = .44) than on the third, which is not surprising in view of the subjective nature of judging exaggeration and inclusion of risks. There was perfect rater agreement (kappa = 1) on the third item: whether the story presented a balanced selection of expert opinion. This item requires much less subjective assessment than do the first two.
Reliability of the third part of the instrument (overall quality) was also low (kappa = .27). Our effort to collapse the original 5-point score into a 3-point score is instructive on the measurement of reliability. The kappa barely improved (kappa = .28), but interobserver agreement jumped from 48 percent to 88 percent. This discrepancy is due to the very small difference between expected cell values and observed cell values, the basis of the calculation of kappa, using either the 5-point or the 3-point scale. Both content and balance scores correlated with overall assessment scores, suggesting that raters took both content and balance into account in their overall assessment. However, the highest overall quality scores were not always those with the highest number of accurate content items but rather stories with more balance.
Lack of balance took several forms. Nearly one-fifth of the stories that described a clinical application (item 36) of one of the discoveries failed to mention an estimated time when the application(s) would be available. Others exaggerated the nearness of the applications, which can lead the public to expect a great number of predictive and diagnostic genetic tests to materialize sooner than is likely (Tambor et al. 2002) . More than half failed to mention that the discovery was applicable to high-risk families. According to our raters, a majority of the stories failed to mention possible risks of the discovery, and more than one-quarter exaggerated the benefits. Because of such deficiencies, people may believe that the discovery of new genes will have immediate implications for broad segments of the population (Bernhardt et al. 2000) . As Altman (1995) noted, "The danger in making unsupportable and premature claims is that the public may become jaded and a credibility gap may be created for . . . science in general" (p. C3).
The ability of our instrument to document variability among stories needs confirmation by applying it to more genetic discoveries. We plan to examine the contribution to variability of the type of media (e.g., print vs. television), the scientific expertise of the journalist, the information presented in the scientific report itself, and other factors. Items could be added to extend the instrument's use to the analysis of stories reporting the development of a genetic test, the relationship between genetics and health, gene therapy, genetic enhancement, or other specialized areas. Some of the items can also serve as the basis for evaluating media reports of scientific discoveries other than genetics that have medical or healthcare applications/implications.
The items in this instrument could be useful in guiding journalists and in teaching students, healthcare providers, and policy makers and the public on what to look for in media stories reporting genetic discoveries. 
